The Search for a New Marker of Renal Function in Older Patients with Chronic Kidney Disease Stages 3-4: Usefulness of Cystatin C-Based Equations

被引:7
|
作者
Fontsere, Nestor [1 ]
Esteve, Vicens [5 ]
Saurina, Ana [5 ]
Pou, Monica [5 ]
Barba, Nuria [6 ]
Deulofeu, Ramon [2 ]
Di Gregorio, Silvana [3 ]
Miguel del Rio, Luis [3 ]
Rios, Jose [4 ]
Torres, Ferran [4 ]
Maduell, Franscesc [1 ]
Campistol, Josep M. [1 ]
Ramirez de Arellano, Manel [5 ]
机构
[1] Hosp Clin Barcelona, Dept Nephrol, ES-08036 Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Lab Med, ES-08036 Barcelona, Spain
[3] Univ Autonoma Barcelona, Cetir Grp Med Barcelona, E-08193 Barcelona, Spain
[4] Univ Autonoma Barcelona, Epidemiol & Biostat Lab, E-08193 Barcelona, Spain
[5] Consorci Sanitari Terrassa, Dept Nephrol, Barcelona, Spain
[6] Consorci Sanitari Terrassa, Dept Lab Med, Barcelona, Spain
来源
NEPHRON CLINICAL PRACTICE | 2009年 / 112卷 / 03期
关键词
Advanced age; Chronic kidney disease stages 3-4; Cystatin C; Conventional prediction equations; Glomerular filtration rate; GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; PREDICTION; MORTALITY; MASS;
D O I
10.1159/000214212
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aim: Cystatin C (Cys C) is an endogenous marker of glomerular filtration rate (GFR) unaffected by body composition. The aim of the present study was to assess the utility of Cys C-based GFR prediction equations (Hoek, Larsson and Stevens) and creatinine (modification of diet in renal disease-isotope dilution mass spectrometry - MDRD-IDMS, and Cockcroft-Gault - CG) compared with Cr-51-EDTA. Methods: This study was carried out in 40 Caucasian older patients with advanced age (>= 60) and chronic kidney disease stages 3-4. To assess the utility of prediction equations in relation to body composition, we measured lean mass (LM) with densitometry (DXA). Pearson's, Bland-Altman and Lin's coefficient (Rc) were used to study accuracy and precision. Results: Cr-51-EDTA was 36.9 +/- 9.2 ml/min/1.73 m(2) (22-60). Cys C levels were 2.2 +/- 0.8 mg/l (r = 0.085; p = 0.662 LM) and creatinine 2.8 +/- 1.1 mg/dl (r = 0.427; p = 0.021 LM). The most accurate equations were the Hoek, Larsson and Stevens formulae, with a bias of -0.2 (Rc 0.48), -2.9 (Rc 0.44) and 2.6 ml/min/1.73 m(2) (Rc 0.58). The biases obtained with MDRD-IDMS and CG were -14.6 (Rc 0.35) and -12.5 (Rc 0.40). All correlations among biases obtained with creatinine-based formulae and LM were negative and statistically significant (p < 0.05). Conclusions: The results show superiority of Cys C-based GFR formulae over the MDRD-IDMS and CG equations. This significant underestimation obtained with conventional prediction equations was directly related to the influence of LM. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:C164 / C170
页数:7
相关论文
共 45 条
  • [21] The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis
    Krones, Elisabeth
    Fickert, Peter
    Zitta, Sabine
    Neunherz, Stefan
    Artinger, Katharina
    Reibnegger, Gilbert
    Durchschein, Franziska
    Wagner, Doris
    Stojakovic, Tatjana
    Stadlbauer, Vanessa
    Fauler, Guenter
    Stauber, Rudolf
    Zollner, Gernot
    Kniepeiss, Daniela
    Rosenkranz, Alexander R.
    BMC NEPHROLOGY, 2015, 16
  • [22] Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease
    Hojs, R.
    Bevc, S.
    Ekart, R.
    Gorenjak, M.
    Puklavec, L.
    CLINICAL NEPHROLOGY, 2008, 70 (01) : 10 - 17
  • [23] Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease
    Vasilyeva, M. P.
    Rudenko, T. E.
    Kutyrina, I. M.
    Solomakhina, N. I.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (06) : 17 - 22
  • [24] Potassium metabolism in patients with chronic kidney disease (CKD), Part I: Patients not on dialysis (stages 3-4)
    Musso C.G.
    International Urology and Nephrology, 2004, 36 (3) : 465 - 468
  • [25] Serum cystatin C as a marker of glomerular kidney damage in patients with chronic glomerulonephritis with saved renal function
    Kraydashenko, O. V.
    Dolinna, M. A.
    ZAPOROZHYE MEDICAL JOURNAL, 2015, (03) : 29 - 33
  • [26] Comparison of cystatin C-based estimated glomerular filtration rate with measured glomerular filtration rate in a pediatric cohort of patients with chronic kidney disease
    Lindvig, Tilde Ostendorf
    Simonsen, Jane Angel
    Gerke, Oke
    Thiesson, Helle Charlotte
    PEDIATRIC TRANSPLANTATION, 2024, 28 (04)
  • [27] The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis
    Elisabeth Krones
    Peter Fickert
    Sabine Zitta
    Stefan Neunherz
    Katharina Artinger
    Gilbert Reibnegger
    Franziska Durchschein
    Doris Wagner
    Tatjana Stojakovic
    Vanessa Stadlbauer
    Günter Fauler
    Rudolf Stauber
    Gernot Zollner
    Daniela Kniepeiss
    Alexander R. Rosenkranz
    BMC Nephrology, 16
  • [28] Improved glomerular filtration rate estimation using New equations combined with standardized cystatin C and creatinine in Chinese adult chronic kidney disease patients
    Guo, Xiuzhi
    Qin, Yan
    Zheng, Ke
    Gong, Mengchun
    Wu, Jie
    Shou, Weiling
    Cheng, Xinqi
    Xia, Liangyu
    Xu, Ermu
    Li, Xuemei
    Qiu, Ling
    CLINICAL BIOCHEMISTRY, 2014, 47 (13-14) : 1220 - 1226
  • [29] Chronic kidney disease - Epidemiology collaboration equations even using cystatin C overestimate renal function in patients with chronic intestinal failure on long-term parenteral nutrition
    Kosmadakis, Georges
    Derain-Dubourg, Laurence
    Lauverjat, Madeleine
    Charlotte, Bergoin
    Lemoine, Sandrine
    Chambrier, Cecile
    CLINICAL NUTRITION ESPEN, 2025, 66 : 390 - 396
  • [30] COMBINING CREATININE-BASED eGFR WITH CYSTATIN C-BASED EGFR TO BETTER ASSESS RENAL FUNCTION IN PATIENTS WITH DIABETES AND CHRONIC KIDNEY DISEASE 3A: IMPLICATIONS FOR DRUG SELECTION AND DOSAGE IN TYPE 2 DIABETES
    Einhorn, Daniel
    Mende, Christian W.
    ENDOCRINE PRACTICE, 2015, 21 (11) : 1301 - 1302